From Cells to New Therapies – The RegMed Track
The RegMed Track links basic molecular and cellular research with translational and clinical studies, and includes stem cell biology, molecular medicine, regenerative biology and translational research. It receives input from theoretical and practical approaches of biophysics, nanobiotechnology, organic chemistry, and biomaterial sciences, and thus connects and closely interacts with the CellDevo and the BioPhysEng Track. The purpose of the RegMed Track is to bridge between natural sciences and medicine, and to enable PhD students to efficiently identify and address scientific problems of medical relevance. The program aims at satisfying the need for integration of natural sciences with medicine, i.e. for translational research.
Research in the RegMed Track focuses on
- development of concepts and approaches for advanced regenerative therapies for cardiovascular, oncological, endocrine, neurodegenerative, hematological/immunological, bone/cartilage and other diseases,
- usage of model organisms to understand and exploit the mechanisms controlling stem and precursor cell generation, maintenance, activation, recruitment, proliferation, homing and differentiation,
- exploration of intra- and intercellular communication, like in the spreading metabolic syndromes, immunological networks, niche interactions,
- control of disease-related cellular processes using genetics, surface engineering, matrix engineering, specifically designed compounds, and microdevices, for example to provide control of stem cell activity and regeneration,
- novel regeneration therapies that are expected to emerge from the above basic studies, pre-clinical and clinical trials, and
- developing basic research insights into diagnostics and therapies and eventually into marketable products.
- Bone Biology
- Cardiovascular Research
- Chromosomal Biology
- Germ Cell Biology
- Stem Cell Biology